Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Spotlight
Screening Familial Risk for Hereditary Breast and Ovarian Cancer
From the abstract: "In a large health system, how many ungenotyped patients meet family history genetic testing criteria for hereditary breast and ovarian cancer? In this cross-sectional analysis, 2.9% of patients had no evidence of prior genetic testing but had electronic health records indicating they met family history criteria. These criteria were associated with significantly increased prevalence of genetic risk variants among 38?003 genotyped patients. These findings suggest that substantial gaps exist in identifying and testing patients meeting family history criteria for hereditary breast and ovarian cancer, and other methods may be needed to close these gaps. "
Harnessing cancer genomes for precision oncology
From the abstract: "Precision oncology has just received a boost: a report on the prevalence of mutations in cancer driver genes based on whole genome sequencing of 10,000 clinical cases. The challenge ahead lies in how to explore the data to accelerate new discoveries in cancer biology while advancing precision oncology. "
Advancing Genomic Cancer Medicine in Rural and Underserved States
From the article: "In the evolving landscape of oncology, the integration of powerful genomic technologies into practice has ushered in a new era of precision cancer medicine. Complex genomic information such as mutational analyses, transcriptional signatures, and polygenic risk scores have become key diagnostics guiding therapeutic decisions and management of inherited cancer risk. However, the expertise to interpret these data for clinical decision-making remains constrained and is a significant challenge for community oncologists, especially those in rural regions and in medically underserved areas. While physical access to these tests is readily available, poor access to interpretive expertise has become the key limiting factor. "
Benefits for children with suspected cancer from routine whole-genome sequencing
From the abstract: " Clinical whole-genome sequencing (WGS) has been shown to deliver potential benefits to children with cancer and to alter treatment in high-risk patient groups. It remains unknown whether offering WGS to every child with suspected cancer can change patient management. We collected WGS variant calls and clinical and diagnostic information from 281 children (282 tumors) across two English units (n=152 from a hematology center, n?=?130 from a solid tumor center) where WGS had become a routine test. Our key finding was that variants uniquely attributable to WGS changed the management in ~7% (20 out of 282) of cases while providing additional disease-relevant findings, beyond standard-of-care molecular tests, in 108 instances for 83 (29%) cases."
Latest
News and Publications
Zhou Sitong, et al. Scientific reports 2024 0 0. (1) 24645
The IFN-induced protein IFI27 binds MDA5 and counteracts its activation after SARS-CoV-2 infection.
Rivero Vanessa, et al. Frontiers in cellular and infection microbiology 2024 0 0. 1470924
In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells.
Serwaa Alberta, et al. Scientific reports 2024 0 0. (1) 24625
[Medical clinical diagnostics for indoor mould exposure - Update 2023 (AWMF Register No. 161/001)].
Hurraß Julia, et al. Pneumologie (Stuttgart, Germany) 2024 0 0. (10) 693-784
Determinants of Breast Cancer Screening Adherence During the COVID-19 Pandemic in a Cohort at Increased Inherited Cancer Risk in the United States.
Harris Adrian, et al. Cancer control : journal of the Moffitt Cancer Center 2024 0 0. 10732748241272727
Exploring the changing landscape of medical imaging: insights from highly cited studies before and during the COVID-19 pandemic.
Ou Peiling, et al. European radiology 2024 0 0.
Impact of the COVID-19 Prioritization Recommendations on Pathological Stages of Urologic Malignancies: A Real-World Analysis at a High-Volume Referral Institution.
Grosso Antonio Andrea, et al. Journal of clinical medicine 2024 0 0. (19)
The Challenges of Treating a Helicobacter pylori Infection following the COVID-19 Pandemic in Croatia: A Review.
Jukic Ivana, et al. Journal of clinical medicine 2024 0 0. (19)
Unusual Presentation of Metastatic Medullary Thyroid Cancer Involving Bone Marrow, Kidneys, and Adrenal Gland: A Literature Review Based on a Case Report.
Ebrahimi Pouya, et al. Cancer reports (Hoboken, N.J.) 2024 0 0. (10) e70022
Remdesivir-associated survival outcomes among immunocompromised patients hospitalized for COVID-19: real-world evidence from the Omicron dominant era.
Mozaffari Essy, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 0 0.
Thyroid Cancer Incidence During 2020 to 2021 COVID-19 Variant Waves.
Bell Rebecca, et al. JAMA otolaryngology-- head & neck surgery 2024 0 0.
Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids.
Salve Buddhabhushan Girish, et al. Immunogenetics 2024 0 0.
Optimal surgical timing for lung cancer following SARS-CoV-2 infection: a prospective multicenter cohort study.
Shen Ziyun, et al. BMC cancer 2024 0 0. (1) 1250
The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials.
Tapescu Iulia, et al. Frontiers in oncology 2024 0 0. 1454370
Modeling respiratory tract diseases for clinical translation employing conditionally reprogrammed cells.
Daneshdoust Danyal, et al. Cell insight 2024 0 0. (6) 100201
Fluoroamphiphiles for enhancing immune response of subunit vaccine against SARS-CoV-2.
Li Yuan, et al. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 2024 0 0. 114528
Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology.
Ma Xiao, et al. Frontiers in medicine 2024 0 0. 1428973
Cancer genetic counseling via telegenetics and telephone: A qualitative study exploring the experience of patients and genetic counselors in an Australian cancer genetics context.
Finney Jessica, et al. Journal of genetic counseling 2024 0 0.
Detection of Neutralizing Antibodies in Serum Samples Using a SARS-CoV-2 Pseudotyped Virus Assay.
Ferrero Sol, et al. Current protocols 2024 0 0. (10) e70025
India's Potential as a Leader in Cancer Care Progress in the Future: A Synthetic Interdisciplinary Perspective.
Singh Anshul, et al. Cureus 2024 0 0. (10) e70892
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: